The present study investigated whether baroreflex control of autonomic function is impaired when there is a deficiency in NO production and the role of adrenergic and cholinergic mechanisms in mediating reflex responses. Electrical stimulation of the aortic depressor nerve in conscious normotensive and L-NAME-induced hypertensive rats was applied before and after administration of methylatropine, atenolol, and prazosin alone or in combination. The hypotensive response to progressive electrical stimulation (5 to 90 Hz) was greater in hypertensive (-27±2 to -64±3 mmHg) than in normotensive rats (-17±1 to -46±2 mmHg) while the bradycardic response was similar in both groups (-34±5 to -92±9 and -21±2 to -79±7 bpm, respectively). Methylatropine and atenolol showed no effect in the hypotensive response in either group. Methylatropine blunted the bradycardic response in both groups, while atenolol attenuated only in hypertensive rats.
Introduction
Quite recently, there has been renewed interest in using electrical stimulation of baroreceptor afferents to lower the arterial pressure of patients with refractory hypertension (13, 43, 50) . Studies carried out in conscious normotensive and hypertensive dogs and patients submitted to chronic electrical stimulation of the carotid sinus have provided further insight into baroreflex regulation of arterial pressure (6, 15, 17, 22, 23, 24, 25) . The hypotensive and bradycardic responses caused by electrical activation of the baroreflex under pathophysiological conditions are mainly considered a result of cardiovascular responses caused by inhibition of the sympathetic and activation of the parasympathetic nervous system.
Our laboratory has developed a means of stimulating the aortic depressor nerve (ADN) in conscious freely moving rats that permits evaluation of the acute reflex bradycardia and hypotensive responses as well as the changes in the vascular resistance of the regional beds in conscious rats without the undesirable effect of the anesthesia (3) . In a recent study, Salgado et al (35) demonstrated that electrical stimulation of the ADN of conscious spontaneously hypertensive rats (SHR) produced equivalent or even greater depressor responses, as compared to normotensive rats, and that withdrawal of sympathetic activity contributes significantly to baroreflex-mediated bradycardia in SHR but not in normotensive rats. Thus, the authors suggested that conscious SHR have well-preserved baroreflex responses that reflect alterations in central baroreflex control and high resting sympathetic activity, characteristics of SHR, susceptible to inhibition by strong baroreceptor input (35).
Chronic blockade of nitric oxide synthase (NOS) by means of N-nitro-L-
arginine methyl ester (L-NAME) provides an experimental model of arterial hypertension that is chronically sustained throughout the period of the blockade (34). It is well documented that nitric oxide (NO) plays a role in the control of arterial pressure acting both peripherally (33) and centrally (4, 10, 45) . In addition, it has been consistently demonstrated that chronic inhibition of NO causes attenuation of the reflex control of arterial pressure (38,40,46).
The reflex bradycardia elicited by the stimulation of baroreceptor afferents is mainly mediated by the parasympathetic nervous system in conscious rats (2, 12, 41) . On the other hand, studies have demonstrated that the reflex hypotensive response to electrical stimulation of baroreceptor afferents is almost exclusively due to the sympathoinhibition (3, 9, 35 ), but there is also a small contribution of postganglionic lumbar sympathetic vasodilators fibers which release nitrosyl factors (32). Therefore, we hypothesized that the reflex control of autonomic function is impaired when there is a deficiency in NO production. Thus, we examined the reflex bradycardia and hypotension produced by electrical stimulation of the ADN in rats chronically treated with L-NAME. Further, since the hemodynamic response to electrical activation of the baroreflex is classically considered a consequence of inhibition of the sympathetic activity to the heart (mediated by β 1 adrenergic receptor) and vessels (mediated by α 1 adrenergic receptor) and activation of parasympathetic activity to the heart (mediated by M 2 muscarinic receptors), we determined the role of these actions in mediating the cardiovascular responses to baroreflex activation by using selective adrenergic and muscarinic antagonists.
Material and Methods

Animal Preparation
The experiments were conducted on male Wistar rats (180-220g) that were maintained in a controlled environment with a constant 12:12-hour light-dark cycle and provided with food and water ad libitum. All procedures were reviewed and approved by the Committee of Ethics in Animal Research at the University of São Paulo, School of Medicine at Ribeirão Preto. All drugs used were purchased from Sigma-Aldrich, Saint Louis, MO, USA,
The rats received L-NAME (~70 mg/kg/day) for two weeks, dissolved in drinking water, while the controls received only water. Systolic blood pressure was measured indirectly in the conscious state by means of the tail-cuff method (IITTC Inc. Life Science, Woodland Hills, CA, USA) right before the beginning of L-NAME administration and on the 7 th and 13 th day of treatment. On the day before the experiment, under thiopental sodium anesthesia (40 mg/kg, ip), the rats were submitted to the procedures to isolate the left ADN to implant the electrodes and to insert catheters into the femoral artery and vein (3, 35) . Briefly, the rats were submitted to ventral neck surgery and, under the microscope, a 4-6 mm length of the left ADN was carefully isolated below its joint with the superior laryngeal nerve.
The ADN was placed on a bipolar stainless steal electrode with an interelectrode distance of 2 mm. The electrodes were constructed by attaching two 40 mm stainless steal wires (0.008" bare, 0.011" teflon coated, A-M Systems, Inc, Sequim, WA) to a small plug (GF-6, Microtech, Inc, Boothwyn, PA). The bared tips of the electrodes consisted of 2 mm length forming a hook where the ADN was placed.
The correct identification of the nerve was confirmed by its typical pattern of discharge synchronous with arterial pulse pressure. After identification of the ADN, the bipolar stainless steal electrode supporting a short segment of the ADN was carefully covered with silicone impression material (Kwik-Sil Silicone Elastomer, World Precision Instruments Inc., Sarasota, FL, USA). A 30-min period was allowed for complete polymerization of the silicone impression material, and the activity of the nerve was recorded again to confirm the integrity of the signal. Next, the fine platinum wires of the electrodes were exteriorized on the back of the rats and soldered to a small plug that was later connected with the wires from the electrical stimulator. Under the same anesthesia, the femoral artery and vein were catheterized with polyethylene tubing (PE-50 and PE-10, Intramedic; Becton Dickinson, Sparks, MD, USA) for recording pulsatile arterial pressure and for intravenous drug administration, respectively. Catheters were exteriorized on the back of the rats, and surgical incision sites were closed by sutures. Twenty-four hours after the end of the surgery, the rats were connected to the recording system, which consisted of a pressure transducer (MLT844, ADInstruments, Sydney, Australia) and an electrical stimulator (AVS-40C, São Paulo, Brazil). Only the rats that showed no signals of pain with electrical stimulation of the ADN were used in the study. The signal, i.e. pulsatile arterial pressure, was amplified (ML224, ADInstruments, Sydney, Australia), fed to an IBM/PC connected with a Power Lab system (ML866/P, ADInstruments, Sydney, Australia) and continuously sampled (2 kHz). Mean arterial pressure (MAP) and heart rate (HR) were calculated from the arterial pulse pressure.
Experimental Protocol
The experimental protocol consisted of a basal recording of cardiovascular variables (MAP and HR) for at least 10 min, followed by a series of electrical In experimental protocol 1 (n=7 normotensive, 325±8g; n=7 L-NAME hypertensive rats, 320±7g), the muscarinic blocker methylatropine (2 mg/kg, iv) was administered and the efficacy of the blockade was verified by the blunted reflex bradycardic response (control: 97±2%, L-NAME: 91±4%) to the pressor response induced by phenylephrine (5 μg/kg, iv). The drug used in experimental protocol 2 (n=7 normotensive, 307±15g; n=7 L-NAME hypertensive rats, 284±7g) was the β 1 -adrenergic-receptor blocker atenolol (2 mg/kg, iv), and the efficacy of the blockade was verified by the blunted tachycardic response to isoproterenol (1μg/kg, iv) in control (82±3%) and L-NAME (82±4%) rats. In experimental protocol 3 (n= 8 normotensive, 341±9g; n= 8 L-NAME hypertensive rats, 283±5g), the α 1 -adrenergic-receptor blocker prazosin (1 mg/kg, iv) was administered and the efficacy of the blockade was verified by the blunted hypertensive response (control: 97±1%, L-NAME: 90±2%) to phenylephrine. To circumvent the fall in MAP caused by prazosin administration, the experimental protocol 4 (n=7 normotensive, 336±8g; n=7 L-NAME hypertensive rats, 330±14g) was carried out. In protocol 4, after prazosin administration (1 mg/kg, iv) an intravenous infusion of angiotensin II (500 ng/kg/min) was used to return the MAP back toward basal levels. In the absence of a fall in MAP, this maneuver permitted a comparison of baroreflexmediated reductions in MAP during α 1 -adrenergic receptor blockade without the confounding influence of reduced base levels of MAP (protocol 3). A combination of the three blockers were used in experimental protocol 5 (n= 8 normotensive, 300±17g; n= 7 L-NAME hypertensive rats, 274±17g), i.e., prazosin, methylatropine, and atenolol, and their efficacy was verified by the blunted response to phenylephrine (control: 90±3%, L-NAME: 95±1%) and to isoproterenol (control: 73±4%, L-NAME: 74±4%) before the triple pharmacological blockade and at the end of the experiment.
Statistical Analysis
Data are presented as mean ± SEM. Baseline values of MAP and HR before and after each drug treatment and between normotensive control and L-NAMEinduced hypertensive rats were compared by paired and unpaired t-test. Systolic blood pressure data and frequency-response to ADN stimulation in L-NAMEinduced hypertensive and normotensive control rats were analyzed by linear regression model with mixed effects (random and fixed effects) followed by orthogonal contrasts (software SAS® 9.1, PROC MIXED) (37). Differences were considered significant when p<0.05.
Results
Basal hemodynamics
Chronic oral administration of L-NAME induced an increase in systolic arterial pressure as measured by the tail-cuff method (from 122±2 to 166±3 and 173±3 mmHg after one and two weeks of L-NAME treatment, respectively), while in normotensive control rats arterial pressure remained stable during the same period (from 126±2 to 124±2 mmHg). L-NAME administration caused a significant increase in MAP and HR (accessed directly from the femoral artery) after two weeks of treatment compared to normotensive control rats (146±2 vs. 105±2 mmHg, p<0.01, and 391±6 vs. 360±5 bpm, p<0.01). 
Hemodynamic responses to electrical stimulation of the ADN
Effects of atenolol on hemodynamic responses to electrical stimulation of the ADN
Atenolol significantly decreased basal HR in L-NAME-induced hypertensive and normotensive control rats but did not change basal MAP in either group ( Table   1 ). The group data for changes in MAP and HR elicited by electrical stimulation of the ADN before and after atenolol are summarized in Figure 4 . In the normotensive control rats, ADN stimulation produced frequency-dependent decreases in both MAP and HR and atenolol did not affect these responses ( Figure 4 ). As observed in the normotensive control rats, atenolol did not influence baroreflex-mediated decreases in MAP in the L-NAME-induced hypertensive group. On the other hand, atenolol significantly attenuated the reflex decreases in HR in the L-NAME-induced hypertensive rats ( Figure 4 ).
Effects of prazosin on hemodynamic responses to electrical stimulation of ADN
Prazosin administration reduced basal MAP to a significantly larger extent in L-NAME-induced hypertensive rats than in normotensive control rats ( Table 1 ).
The fall in MAP produced by prazosin caused reflex tachycardia in both groups (Table 1 ). The group data for changes in MAP and HR elicited by electrical stimulation of the ADN before and after prazosin are summarized in Figure 5 .
Prazosin attenuated the hypotensive response to ADN stimulation in both normotensive control (43% for 90 Hz) and L-NAME-induced hypertensive rats (53% for 90 Hz). Nevertheless, after α 1 -adrenergic receptor blockade, a similar residual fall in MAP was observed in the two groups ( Figure 5 ). The reflex bradycardic response was not affected by prazosin administration in either group ( Figure 5 ).
Effects of prazosin + angiotensin II on hemodynamic responses to electrical stimulation of ADN
Prazosin administration reduced basal MAP in L-NAME-induced hypertensive rats (from 136±3 to 94±8 mmHg, ∆= -43±6, p<0.01) and in normotensive control rats (from 102±2 to 80±3 mmHg, ∆= -22±3, p<0.01) while angiotensin II infusion returned the MAP back toward basal values ( Table 1 ). The fall in MAP produced by prazosin caused reflex tachycardia in both groups (L-NAME: from 389±14 to 480±10 bpm, ∆= 91±15, p<0.01; normotensive: from 333±8 to 385±23 bpm, ∆= 52±21, p<0.05). The group data for changes in MAP and HR elicited by electrical stimulation of the ADN before and after prazosin + angiotensin II are shown in Figure 6 . The hypotensive response to ADN stimulation was attenuated in both the L-NAME-induced hypertensive and normotensive control rats. However, even after α 1 -adrenergic receptor blockade plus the recovery of the groups ( Figure 6 ). The reflex bradycardic response was not affected by prazosin plus angiotensin II in either group.
Effects of triple pharmacological blockade (methylatropine, atenolol, and prazosin) on hemodynamic responses to electrical stimulation of ADN
After administration of all three antagonists, basal MAP decreased in both the L-NAME-induced hypertensive and normotensive control rats while basal HR remained unchanged in both groups ( Table 1 ). The group data for changes in MAP and HR produced by electrical stimulation of the ADN before and after triple pharmacological blockade are summarized in Figure 7 . The triple pharmacological blockade completely abolished the reflex decrease in HR in both groups; however, ADN stimulation still elicited similar residual frequency-dependent decreases in MAP in both the L-NAME-induced hypertensive and normotensive control rats ( Figure 7 ).
Discussion
The results of the present study demonstrated a well preserved baroreflexmediated decrease in MAP and HR in conscious L-NAME-induced hypertensive rats. In addition, it was also demonstrated that inhibition of the sympathetic drive to the heart plays a role in reflex bradycardia only in L-NAME-induced hypertensive rats. Moreover, activation of the ADN still caused a decrease in MAP after α 1 -receptor blockade and after triple combined blockade (methylatropine, atenolol and prazosin) in a hypertensive model lacking NO production.
The fact that NO is involved in different central site of baroreflex regulation (4, 28, 42, 45) and that L-NAME can cross the blood-brain barrier and inhibit NOS in important nuclei responsible for cardiovascular regulation (44,51), suggests that inhibition of NO production in L-NAME-induced hypertensive rats might interfere with the peripheral and/or central processing of the afferent input from electrical stimulation of the ADN. Nevertheless, in the present study it was observed that ADN stimulation evoked greater hypotensive response and similar bradycardia in L-NAME-induced hypertensive rats when compared with normotensive control rats. It has been consistently demonstrated that the reflex bradycardia evoked by increases in arterial pressure is mediated primarily by rapid parasympathetic activation (i.e., approximately 1 s after the arterial pressure reaches its peak) (2, 11, 12, 41) . Nonetheless, some authors have demonstrated that the reflex withdrawal of sympathetic activity also makes a small but somewhat slower contribution to reflex bradycardia (2, 41) . In the present study, the period of electrical stimulation was 20 s. Therefore, the reflex bradycardia elicited by ADN stimulation was due not only to parasympathetic activation, but also to reflex suppression of sympathetic activity. Thus, after the blockade of the parasympathetic system by means of methylatropine, the bradycardia response was almost abolished. However, after methylatropine administration there was a residual bradycardia in both groups, which was caused by the reflex withdrawal of sympathetic activity to the heart. On the other hand, attenuation of the reflex bradycardia did not influence the baroreflex-mediated decrease in MAP in normotensive control and in L-NAME-induced hypertensive rats, in agreement with studies demonstrating that complete autonomic blockade of the heart or vagotomy does not affect the reflex decrease in MAP in anesthetized rats or rabbits (7, 9, 20, 26) or conscious rats (3). Thus, these results indicated that the hypotensive response to ADN stimulation is independent of the bradycardic response and seems to be mainly due to the sympathoinhibition.
The lack of effect of atenolol on baroreflex-mediated hypotension in normotensive control and L-NAME-induced hypertensive rats indicated that the sympathetic withdrawal to the heart did not play a role in the hypotensive response in either group. These findings are similar to those from a previous study which demonstrated that atenolol did not influence the baroreflex-mediated decrease in arterial pressure in normotensive rats or SHR (35). In addition, atenolol did not affect the reflex bradycardia due to ADN stimulation in normotensive rats. This result is in line with the primary role of the parasympathetic drive in mediating reflex bradycardia (2, 11, 41) . Because atenolol attenuated the baroreflex-mediated bradycardia in L-NAME-induced hypertensive rats, this observation indicates that withdrawal of sympathetic activity contributes significantly to baroreflex-mediated bradycardia in L-NAME-induced hypertensive rats, contrasting with normotensive In the present study there was a greater fall in MAP in L-NAME-induced hypertensive than in normotensive control rats in response to prazosin. This greater fall in basal MAP during L-NAME-induced hypertension might be an indirect evidence of sympathetic overactivity in this model of hypertension.
However, a recent study from our laboratory demonstrated that the arterial hypertension induced by L-NAME treatment over the course of 2 and 14 days is not associated with sympathetic overactivity (5). One possible explanation for this larger decrease in MAP may be an enhanced vascular reactivity to the normal sympathetic drive, since previous studies demonstrated an increase in vascular responsiveness to phenylephrine and norepinephrine in rats chronically treated with L-NAME (30,31).
The results from electrical stimulation of the ADN showed that after prazosin the baroreflex-mediated hypotension was markedly attenuated in both normotensive control and L-NAME-induced hypertensive rats, while the reflex bradycardia was not affected in either group. The attenuation of the baroreflexmediated hypotension after prazosin might simply be attributed, in part, to the lower levels of arterial pressure in both groups. However, when MAP was returned to basal levels with angiotensin II after prazosin administration, the same diminished response to ADN stimulation was observed. Therefore, the attenuation In conclusion, baroreflex-mediated stimulation decreases in MAP and HR in conscious L-NAME-induced hypertensive rats were well preserved during ADN stimulation. Withdrawal of the sympathetic drive plays a role in the reflex bradycardia in L-NAME-induced hypertensive but not in normotensive control rats.
However, there was no differential hypotensive response to sympathetic inhibition between normotensive control and L-NAME-induced hypertensive rats. The residual fall in pressure after the triple pharmacological blockade suggests the involvement of a vasodilatory mechanism unrelated to NO and diminished stimulation of α 1 -and β-adrenergic receptors.
Perspectives
In the current study acute electrical stimulation of the ADN in conscious L-NAME-induced hypertensive rats produced a residual fall in pressure after the triple pharmacological blockade (atropine, atenolol and prazosin) suggesting the involvement of a vasodilatory mechanism unrelated to NO and α 1 Values are mean ± SEM. *P<0.01 compared to before drug and †P<0.05 compared to normotensive rats. MAP, mean arterial pressure; HR, heart rate; ∆, changes in basal MAP and HR due to drug administration.
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